Is Low-Risk Prostate Cancer More Indolent in Younger Patients?

J Clin Oncol. 2017 Jun 10;35(17):1870-1871. doi: 10.1200/JCO.2017.72.3684. Epub 2017 Mar 27.
No abstract available

Publication types

  • Editorial
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms*
  • Risk

Substances

  • Prostate-Specific Antigen